Evidence map›Paper›PMID 33027255›Full record

ArticlePloS one2020

Neurosyphilis: Still prevalent and overlooked in an at risk population.

Prashanth S Ramachandran, Rob W Baird, Peter Markey, Sally Singleton, Michael Lowe, Bart J Currie, James N Burrow, Ric N Price

Abstract readMulticenter Study
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Key Considerations in Evaluating Syphilis Therapeutics.Sexually transmitted diseases · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Chemsex and Psychosis: A Systematic Review.Behavioral sciences (Basel, Switzerland) · 2022
    Review
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Prashanth S RamachandranDivision of Medicine, Royal Darwin Hospital, Darwin, NT, Australia.ORCID 0000-0001-8464-1355
Rob W BairdTerritory Pathology, Department of Health, Darwin, NT, Australia.
Peter MarkeyDivision of Medicine, Royal Darwin Hospital, Darwin, NT, Australia.
Sally SingletonCentre for Disease Control, Darwin, Northern Territory, Australia.
Michael LoweDivision of Medicine, Royal Darwin Hospital, Darwin, NT, Australia.
Bart J CurrieDivision of Medicine, Royal Darwin Hospital, Darwin, NT, Australia.ORCID 0000-0002-8878-8837
James N BurrowDivision of Medicine, Royal Darwin Hospital, Darwin, NT, Australia.ORCID 0000-0002-6663-3682
Ric N PriceDivision of Medicine, Royal Darwin Hospital, Darwin, NT, Australia.ORCID 0000-0003-2000-2874

Funding

Wellcome TrustWellcome Trust 200909
6 · The paper itself

Abstract

backgroundNeurosyphilis (NS) presents with a variety of clinical syndromes that can be attributed to other aetiologies due to difficulties in its diagnosis. We reviewed all cases of NS from the "Top End" of the Australian Northern Territory over a ten-year period to assess incidence, clinical and laboratory manifestations.

methodsPatient data (2007-2016) were extracted from hospital records, centralised laboratory data and Northern Territory Centre for Disease Control records. Clinical records of patients with clinically suspected NS were reviewed. A diagnosis of NS was made based on the 2014 US CDC criteria. Results were also recategorized based on the 2018 US CDC criteria.

resultsThe population of the "Top End" is 185,570, of whom 26.2% are Indigenous. A positive TPPA was recorded in 3126 individuals. A total of 75 (2.4%) of TPPA positive patients had a lumbar puncture (LP), of whom 25 (35%) were diagnosed with NS (9 definite, 16 probable). Dementia was the most common manifestation (58.3%), followed by epilepsy (16.7%), psychosis (12.5%), tabes dorsalis (12.5%) and meningovascular syphilis (8.3%). 63% of probable NS cases were not treated appropriately due to a negative CSF VDRL. Despite increased specificity of the 2018 US CDC criteria, 70% of patient in the probable NS group were not treated appropriately. The overall annual incidence [95%CI] of NS was 2.47[1.28-4.31] per 100 000py in the Indigenous population and 0.95[0.50-1.62] in the non-Indigenous population (rate ratio = 2.60 [1.19-5.70];p = 0.017).

conclusionNeurosyphilis is frequently reported in the NT, particularly in Indigenous populations. Disturbingly, 60% of probable neurosyphilis patients based on the 2014 criteria, and 70% based on the 2018 criteria with were not treated appropriately. It is critical that clinicians should be aware of the diagnosis of NS and treat patients appropriately.

Indexed as

AdultAgedAged, 80 and overAnti-Bacterial AgentsCohort StudiesFemaleHumansIncidenceMaleMiddle AgedNeurosyphilisNorthern TerritoryPenicillin G BenzathinePrevalenceProspective StudiesRetrospective StudiesAnti-Bacterial AgentsPenicillin G Benzathine

Identifiers

PMID33027255
PMCPMC7540903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.